Eli Lilly announced a definitive agreement to acquire SGX Pharmaceuticals, a biotech specializing in oncology products, for $64 million, in an all-cash transaction.
Sudler & Hennessey announced the launch of 98.6°, a new patient health division. Jeanne Cloppse, managing director, will oversee the team. Areas of focus include disease state communications, treatment option and decisions, healthcare systems and the importance of compliance.
